Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nursing perspectives on intraperitoneal chemotherapy.

S T Hoff

    Journal of Intravenous Nursing : the Official Publication of the Intravenous Nurses Society
    |September 1, 1991
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Interaction between C-Tb and PPD given concomitantly in a split-body randomised controlled trial.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2018
    Same author

    Author's response: BCG and infection with Mycobacterium tuberculosis.

    Thorax·2014
    Same author

    The effectiveness of BCG vaccination in preventing Mycobacterium tuberculosis infection and disease in Greenland.

    Thorax·2014
    Same author

    Concepts in intraperitoneal chemotherapy.

    Seminars in oncology nursing·1987

    Direct intraperitoneal chemotherapy offers significant advantages for abdominal cancers. This review covers its history, current use, and future potential in cancer treatment.

    Area of Science:

    • Oncology
    • Pharmacology
    • Surgical Oncology

    Background:

    • Intraperitoneal chemotherapy has emerged as a valuable strategy for treating cancers confined to the abdominal cavity.
    • Numerous studies over the past decade have highlighted its pharmacologic benefits compared to systemic administration.
    • This approach leverages direct drug delivery to the tumor site, enhancing local drug concentration.

    Purpose of the Study:

    • To provide a comprehensive overview of intraperitoneal chemotherapy.
    • To explore the historical development, current applications, and future prospects of this treatment modality.
    • To detail the key aspects including therapeutic advantages, agents, delivery systems, administration, toxicity, and nursing care.

    Main Methods:

    • Literature review and synthesis of existing research on intraperitoneal chemotherapy.

    Related Experiment Videos

  • Exploration of historical data, current clinical practices, and emerging trends.
  • Discussion of various chemotherapeutic agents, delivery devices, and administration protocols.

    • Main Results:

    • Intraperitoneal chemotherapy demonstrates considerable pharmacologic advantages for localized abdominal cancers.
    • A wide range of chemotherapeutic agents and delivery systems are utilized.
    • Understanding of administration procedures, potential toxic effects, and essential nursing management is crucial.

    Conclusions:

    • Intraperitoneal chemotherapy represents a significant advancement in the management of abdominal malignancies.
    • Continued research and development are expected to further refine its application and efficacy.
    • Multidisciplinary care, including specialized nursing, is vital for optimal patient outcomes.